Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tranexamic acid to reduce blood loss during rhinoplasty
IRCT201312271674N10Phase 2Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tranexamic acid, sponsored by Shiraz University of Medical Sciences. Primary endpoint: Intraoperative blood loss. Started Mar 2014; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on IRCT201312271674N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201312271674N10.